Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2013
05/14/2013US8440652 MST1 kinase inhibitors and methods of their use
05/14/2013CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
05/14/2013CA2716369C Phenoxypropylamine compounds
05/14/2013CA2611889C Substituted tetrahydroquinolines
05/14/2013CA2589237C (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4­homopiperazine hydrochloride dihydrate
05/14/2013CA2557433C Quinazoline derivatives and therapeutic use thereof
05/14/2013CA2546657C 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/14/2013CA2544814C Non-symmetrical gelling agent
05/14/2013CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/14/2013CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
05/14/2013CA2393084C Immunoassay for neonicotinyl insecticides
05/10/2013WO2013067434A1 Pak inhibitors for the treatment of fragile x syndrome
05/10/2013WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine
05/10/2013WO2013067264A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
05/10/2013WO2013066640A1 Substituted pyrazole analogues as rar antagonists
05/10/2013WO2013064983A1 Benzenesulfonamide compounds and their use as therapeutic agents
05/10/2013WO2013064919A1 Quinazoline derivatives with hsp90 inhibitory activity
05/10/2013WO2013064883A1 Heteroaryl compounds as sodium channel blockers
05/10/2013WO2013064521A1 Pesticidal compounds
05/10/2013WO2013064519A1 Pesticidal compounds
05/10/2013WO2013064468A1 Indole inhibitors of crac
05/10/2013WO2013064465A1 New aryl-quinoline derivatives
05/10/2013WO2013064461A2 Compounds with nematicidal activity
05/10/2013WO2013064458A1 Herbicide/safener compositions containing n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides
05/10/2013WO2013064450A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
05/10/2013WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
05/10/2013WO2013032668A3 Anatabine-enriched tobacco products
05/10/2013WO2013006308A3 Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
05/10/2013WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
05/10/2013WO2012124311A8 Novel phenylpyridine derivative and drug containing same
05/10/2013CA2854462A1 Pak inhibitors for the treatment of fragile x syndrome
05/10/2013CA2854217A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
05/10/2013CA2854107A1 Herbicide/safener compositions containing n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides
05/10/2013CA2853967A1 8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity
05/10/2013CA2853439A1 Benzenesulfonamide compounds and their use as therapeutic agents
05/10/2013CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine
05/10/2013CA2850516A1 Substituted pyrazole analogues as rar antagonists
05/10/2013CA2849945A1 New aryl-quinoline derivatives
05/09/2013US20130116441 Intermediates and process for preparing a thrombin specific inhibitor
05/09/2013US20130116440 Process of preparing a thrombin specific inhibitor
05/09/2013US20130116439 Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds
05/09/2013US20130116431 Novel HSP90 Inhibitor
05/09/2013US20130116430 Novel nicotinamide derivative or salt thereof
05/09/2013US20130116285 Chemical Compounds
05/09/2013US20130116284 Lipoic acid and nitroxide derivatives and uses thereof
05/09/2013US20130116283 Substituted indole derivatives
05/09/2013US20130116281 Multiphoton Activable Quinoline Derivatives, Their Preparation and Their Uses
05/09/2013US20130116279 Bicyclic heteroaryl inhibitors of pde4
05/09/2013US20130116278 Antimicrobial agents
05/09/2013US20130116264 Novel Hetaryl (thio)carboxamide Compounds for Controlling Invertebrate Pests
05/09/2013US20130116258 Androgen receptor modulators and uses thereof
05/09/2013US20130116253 Novel HSP90 Inhibitor
05/09/2013US20130116252 Novel HSP90 Inhibitor
05/09/2013US20130116251 Novel HSP90 Inhibitor
05/09/2013US20130116247 IRE-1alpha INHIBITORS
05/09/2013US20130116246 8-fluorophthalazin-1(2h)-one compounds
05/09/2013US20130116240 Indole compounds and pharmaceutical use thereof
05/09/2013US20130116234 Aryl-quinoline derivatives
05/09/2013US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116231 Tyrosine kinase inhibitors
05/09/2013US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors
05/09/2013US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116228 Thiazoles and pyrazoles useful as kinase inhibitors
05/09/2013US20130116216 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
05/09/2013US20130116214 Heterocyclic ring compound
05/09/2013US20130116206 Quinoline derivatives used as pet imaging agents
05/09/2013US20130116169 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
05/09/2013US20130115194 Hepatitis c virus inhibitors
05/09/2013US20130115193 Hepatitis C Virus Inhibitors
05/09/2013US20130113367 Heterocyclic compound and organic light-emitting device including the same
05/09/2013US20130112948 Heterocyclic compound and organic light-emitting diode including the same
05/08/2013EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
05/08/2013EP2589599A1 Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
05/08/2013EP2589595A1 Agent for treating hcv infection
05/08/2013EP2589592A1 Novel nicotinamide derivatives or salts thereof
05/08/2013EP2589591A1 Compound with carbazole ring structure and organic electroluminescent element
05/08/2013EP2589293A1 Herbicide safener compounds containing N-(Tetrazol-5-yl)- and N-(Triazol-5-yl)aryl carboxylic acid amides
05/08/2013EP2588473A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors
05/08/2013EP2588472A1 Rupatadine salt as an antihistaminic agent
05/08/2013EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588470A1 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
05/08/2013EP2588469A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588468A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588467A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588466A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace)
05/08/2013EP2588465A1 Sgc stimulators
05/08/2013EP2588458A1 Novel tetrahydroquinoline derivatives
05/08/2013EP2588456A1 Novel microbiocidal dioxime ether derivatives
05/08/2013EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
05/08/2013EP2588453A1 Compositions and methods for modulating the wnt signaling pathway
05/08/2013EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders
05/08/2013EP2588104A1 Isoindolone m1 receptor positive allosteric modulators
05/08/2013CN103097376A Pyridine compounds for controlling invertebrate pests ii
05/08/2013CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2
05/08/2013CN103097374A Metalloenzyme inhibitor compounds
05/08/2013CN103097373A Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
05/08/2013CN103097361A 1-(aryl methyl)-quinazoline-2,4-dione as parp inhibitor and its application
05/08/2013CN103097354A Substituted benzamide compounds
05/08/2013CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/08/2013CN103088007A Crystal structure of enterovirus 71 type 2A protease and application of crystal structure in drug design
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 1080